(Q66034429)

English

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

The Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine, in Adults Without Previous Smallpox Vaccination (English)
0 references
0 references
0 references
April 2004
0 references
October 2006
0 references
110
0 references
18 year
0 references
31 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit